Guidance Archives - Page 52 of 637

1 minute read

Why Is SaaS Company Conduent Stock On Fire Today?

May 1, 12:14 PM

Conduent impresses with Q1 FY24 earnings, surpassing analyst expectations. Despite a slight sales dip of 0.1% Y/Y to $921 million, the company outperformed consensus estimates. Notably, total operating costs and expenses saw a significant 14.6% decline to $794 million.

CNDT

1 minute read

Johnson Controls Dips Over 6% After Q2 Earnings – Here’s Why

By Nabaparna Bhattacharya

May 1, 12:05 PM

Johnson Controls' shares drop post-Q2 earnings, despite beating EPS estimates, as sales miss and a $750 million charge weigh on investor sentiment.

JCI

2 minute read

Mastercard Says Consumer Spending Is Healthy, Clocks 10% Revenue Growth In Q1

By Anusuya Lahiri

May 1, 11:16 AM

Mastercard Inc (NYSE: MA) reported fiscal Q1 2024 results with net revenues of $6.35B, beating consensus of $6.34B. Adjusted EPS rose 18% to $3.31. Payment network net revenue rose 7%. Outlook: high-single-digit net revenue growth for Q2 and low-double-digit growth for FY2024.

IYG

2 minute read

Why Is Norwegian Cruise Line Stock Sinking Today?

By Akanksha Bakshi

May 1, 11:11 AM

Norwegian Cruise Line reported first-quarter fiscal 2024 sales growth of 20.3% year-on-year to $2.191 billion on 8% capacity growth, missing the consensus of $2.24 billion. Adjusted EPS improved to $0.16 from $(0.30) a year ago, beating the consensus of $0.11.

NCLH

1 minute read

AI Beneficiary Flex Stock Declines After Q4 Print, What’s Going On?

By Anusuya Lahiri

May 1, 11:04 AM

Flex Ltd (NASDAQ: FLEX) reported strong 4Q 2024 results, beating analyst estimates. Gross margin and operating margin also improved. Outlook for 2025 looks positive. Stock declined after earnings.

AAPL

2 minute read

What’s Going On With KKR Shares Wednesday?

By Lekha Gupta

May 1, 10:50 AM

KKR reported higher Q1 FY24 results but missed revenue estimates. AUM rose 13% to $578B, with a dividend of $0.175/share.

FMCX

2 minute read

Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To Perform Consistently With Expectations

By Vandana Singh

May 1, 10:38 AM

Pfizer reports Q1 results: adjusted EPS beats estimates, driven by revenue growth. Significant declines in Comirnaty and Paxlovid revenues countered by operational gains. Company announces plans for direct-to-consumer online platform.

LLY

2 minute read

What’s Going On With Restaurant Chain Wingstop Shares Today?

By Shivani Kumaresan

May 1, 10:35 AM

Wingstop reported Q1 FY24 sales surge 34.1% YoY to $145.789M, surpassing estimates. Adjusted EPS of $0.98 beat the consensus estimate of $0.76.

WING

2 minute read

Barrick Gold Maintains FY24 Outlook Despite Q1 Production Miss

By Lekha Gupta

May 1, 10:16 AM

Barrick Gold reported first-quarter revenue of $2.747 billion (+4% Y/Y), which is in line with the consensus. Gold production stood at 940 thousand ounces (-1% Y/Y), and gold sales were 910 thousand ounces (-5% Y/Y).

GDX